• Skip to main content
  • Skip to site footer
Simon & Company - Experts in Health & Human Services Policy

Simon&Co., LLC

Experts in Health and Human Services Policy, Appropriations, & Budget Strategies

  • Home
  • Issues
    • Drug Pricing
    • Income Security
    • Medicaid
    • Medicare
    • Non-Emergency Medical Transport
    • Program Integrity
    • Public Health
    • Safety-Net Programs
    • Women’s Reproductive Health
  • Services
  • Clients
  • Press
  • About
  • Contact
  • Home
  • Issues
    • Drug Pricing
    • Income Security
    • Medicaid
    • Medicare
    • Non-Emergency Medical Transport
    • Program Integrity
    • Public Health
    • Safety-Net Programs
    • Women’s Reproductive Health
  • Services
  • Clients
  • Press
  • About
  • Contact
Home » Drug Pricing

Drug Pricing

Links to Sub-topics:

  • Medicaid Rebate Program
  • 340B
  • Vaccines for Children
  • Federal Supply Schedule
  • National Strategic Stockpile
  • Non-Profit Drug Development

Simon&Co. has extensive knowledge of the Medicaid drug rebate program and how it interacts with other programs such as 340B and the Department of Veterans Affairs Federal Supply Schedule System. We have helped our clients navigate these complexities to understand the impact on clinics and their patients of plan and state formularies.

Medical scientist working in lab

VA ACQUISITION MANAGEMENT: Steps Needed to Ensure Healthcare Federal Supply Schedules Remain Useful

November 20, 2023
Read moreVA ACQUISITION MANAGEMENT: Steps Needed to Ensure Healthcare Federal Supply Schedules Remain Useful

Simon&Co. Summary of Efforts in Support of Department of Veterans Affairs

November 15, 2023
Read moreSimon&Co. Summary of Efforts in Support of Department of Veterans Affairs

Grants to Create State Strategic Stockpiles

November 15, 2023
Read moreGrants to Create State Strategic Stockpiles

CRS Report: SNS Overview

November 15, 2023
Read moreCRS Report: SNS Overview

Bipartisan Pandemic Response Bill is Signed into Law, Includes Directive on SNS

November 15, 2023
Read moreBipartisan Pandemic Response Bill is Signed into Law, Includes Directive on SNS

Vaccines for Children Program: Early Legislative History and Future Innovations report

October 12, 2023
Read moreVaccines for Children Program: Early Legislative History and Future Innovations report

OPA Audit Findings of Violations of the GPO Exclusion: FY12-FY17

October 12, 2023
Read moreOPA Audit Findings of Violations of the GPO Exclusion: FY12-FY17

Forbes: Could The Most Effective Birth Control Soon Become The Cheapest?

August 25, 2023
Read moreForbes: Could The Most Effective Birth Control Soon Become The Cheapest?

VFC Program Distribution of Pediatric Vaccines

August 25, 2023
Read moreVFC Program Distribution of Pediatric Vaccines

Vaccines for Children Program: Vulnerabilities in Vaccine Management

August 24, 2023
Read moreVaccines for Children Program: Vulnerabilities in Vaccine Management

Vaccines National Strategic Plan

August 24, 2023
Read moreVaccines National Strategic Plan

CRS Report on the Strategic National Stockpile

August 24, 2023
Read moreCRS Report on the Strategic National Stockpile

Grants to Create State Strategic Stockpiles

August 24, 2023
Read moreGrants to Create State Strategic Stockpiles

Bipartisan Pandemic Response Bill is Signed into Law, Includes Directive on SNS

August 24, 2023
Read moreBipartisan Pandemic Response Bill is Signed into Law, Includes Directive on SNS

Marsha Simon Comments on the Inflation Rebate Policies in the IRA

October 5, 2022
Read moreMarsha Simon Comments on the Inflation Rebate Policies in the IRA

Marsha Simon Quoted in 340B Health on Orrin Hatch’s Death and His Ties to the 340B Program

June 8, 2022
Read moreMarsha Simon Quoted in 340B Health on Orrin Hatch’s Death and His Ties to the 340B Program

MedPage Today Quotes Marsha Simon on Drug Provisions in Bipartisan Infrastructure Bill

November 11, 2021
Read moreMedPage Today Quotes Marsha Simon on Drug Provisions in Bipartisan Infrastructure Bill

MedPage Today Quotes Marsha Simon on Biden Executive Order Targeting Pharmaceutical Competition

July 14, 2021
Read moreMedPage Today Quotes Marsha Simon on Biden Executive Order Targeting Pharmaceutical Competition

MedPage Today Quotes Marsha Simon on ‘Most-Favored Nation’ Drug Pricing Rule

January 14, 2021
Read moreMedPage Today Quotes Marsha Simon on ‘Most-Favored Nation’ Drug Pricing Rule

Marsha Comments on Drug Pricing Policy under Potential Biden Administration

November 5, 2020
Read moreMarsha Comments on Drug Pricing Policy under Potential Biden Administration

Marsha Simon Gives Her Thoughts on Recent 340B Policy Developments and the Odds for Passage of 340 Legislation

October 20, 2020
Read moreMarsha Simon Gives Her Thoughts on Recent 340B Policy Developments and the Odds for Passage of 340 Legislation

Marsha Quoted in MedPage Today, on Whether States Can Regulate PBMs

October 9, 2020
Read moreMarsha Quoted in MedPage Today, on Whether States Can Regulate PBMs

Marsha Simon Comments on Pelosi Drug Bill

September 20, 2019
Read moreMarsha Simon Comments on Pelosi Drug Bill

Marsha Simon, Simon&Co. President, comments on Gottlieb Departure from FDA

March 14, 2019
Read moreMarsha Simon, Simon&Co. President, comments on Gottlieb Departure from FDA
  • Page 1
  • Page 2
  • Next

Simon&Co., LLC
202-204-4707
1155 15th Street NW
Suite 403
Washington, DC 20005

  • LinkedIn
  • X

© 2026 · Simon & Co · All Rights Reserved